ORIGINAL ARTICLE
Ahead of Print

The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database


 Department of Urology, Institute of Urology, West China Hospital of Sichuan University, Chengdu 610041, China

Correspondence Address:
Lu Yang,
Department of Urology, Institute of Urology, West China Hospital of Sichuan University, Chengdu 610041
China
Qiang Wei,
Department of Urology, Institute of Urology, West China Hospital of Sichuan University, Chengdu 610041
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aja202159

PMID: 34596600

To reduce treatment-related side effects in low-risk prostate cancer (PCa), both focal therapy and deferred treatments, including active surveillance (AS) and watchful waiting (WW), are worth considering over radical prostatectomy (RP). Therefore, this study aimed to compare long-term survival outcomes between focal therapy and AS/WW. Data were obtained and analyzed from the Surveillance, Epidemiology, and End Results (SEER) database. Patients with low-risk PCa who received focal therapy or AS/WW from 2010 to 2016 were included. Focal therapy included cryotherapy and laser ablation. Multivariate Cox proportional hazards models were used to compare overall mortality (OM) and cancer-specific mortality (CSM) between AS/WW and focal therapy, and propensity score matching (PSM) was performed to reduce the influence of bias and unmeasured confounders. A total of 19 292 patients with low-risk PCa were included in this study. In multivariate Cox proportional hazards model analysis, the risk of OM was higher in patients receiving focal therapy than those receiving AS/WW (hazard ratio [HR] = 1.35, 95% confidence interval [CI]: 1.02–1.79, P = 0.037), whereas no significant difference was found in CSM (HR = 0.98, 95% CI: 0.23–4.11, P = 0.977). After PSM, the OM and CSM of focal therapy and AS/WW showed no significant differences (HR = 1.26, 95% CI: 0.92–1.74, P = 0.149; and HR = 1.26, 95% CI: 0.24–6.51, P = 0.782, respectively). For patients with low-risk PCa, focal therapy was no match for AS/WW in decreasing OM, suggesting that AS/WW could bring more overall survival benefits.


[FULL TEXT] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Yuan QM
    -  Lin TH
    -  Jin K
    -  Qiu S
    -  Zhou XH
    -  Jin D
    -  Li JK
    -  Yang L
    -  Wei Q
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed669    
    PDF Downloaded36    

Recommend this journal